In just concluded Meeting of Board of Directors, the Board approved and considered the following items: 1. Unaudited (Standalone and Consolidated) Financial Statements for the Quarter ended June 30, 2025 (annexed herewith); 2. Limited Review Reports from the Statutory Auditors on Unaudited (Standalone and Consolidated) Financial Statements for the quarter ended June 30, 2025 (annexed herewith); 3. Other Business items. We hereby submit that the Board Meeting had commenced at 4.00 PM and concluded at 4.40 PM. This intimation is also uploaded on the Company website: www.gennexlab.com. We request you to take the above information on record and acknowledge the receipt of the same.
